MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35378724

about

MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma MicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic Considerations Hepatitis B Virus Infection, MicroRNAs and Liver Disease Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention TBCK influences cell proliferation, cell size and mTOR signaling pathway Insulin promotes glucose consumption via regulation of miR-99a/mTOR/PKM2 pathway Overexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growth MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways miRNAs affect the development of hepatocellular carcinoma via dysregulation of their biogenesis and expression.A novel small-molecule compound diaporine A inhibits non-small cell lung cancer growth by regulating miR-99a/mTOR signaling.MicroRNAs associated with HBV infection and HBV-related HCC.Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection.Hepatitis B virus-specific miRNAs and Argonaute2 play a role in the viral life cycle.MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma Regulation of IGF -1 signaling by microRNAs.MicroRNA Profiling of Laser-Microdissected Hepatocellular Carcinoma Reveals an Oncogenic Phenotype of the Tumor Capsule Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells Up-regulation of microRNA-190b plays a role for decreased IGF-1 that induces insulin resistance in human hepatocellular carcinoma.MiR-99a antitumor activity in human breast cancer cells through targeting of mTOR expression.Characterisation and comparison of lactating mouse and bovine mammary gland miRNomes.The "Macro" World of microRNAs in Hepatocellular Carcinoma.Low mir-372 expression correlates with poor prognosis and tumor metastasis in hepatocellular carcinoma IFI35, mir-99a and HCV genotype to predict sustained virological response to pegylated-interferon plus ribavirin in chronic hepatitis C.Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway MicroRNAs: Emerging Novel Clinical Biomarkers for Hepatocellular Carcinomas.MiR-940 inhibits hepatocellular carcinoma growth and correlates with prognosis of hepatocellular carcinoma patients.MiR-1 downregulation correlates with poor survival in clear cell renal cell carcinoma where it interferes with cell cycle regulation and metastasis.Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma MiR-1271 Inhibits Ovarian Cancer Growth by Targeting Cyclin G1.miR-96, miR-145 and miR-9 expression increases, and IGF-1R and FOXO1 expression decreases in peripheral blood mononuclear cells of aging humans.Long noncoding RNAs in diseases of aging.

P2860

Q26765476-606E5020-339B-4F22-A08F-74F4F01E65DD Q26766068-83AD7279-7EA5-4796-83C9-CBF0983B9B28 Q26773183-48B9F8F5-D1A6-45DB-B6C2-0B74FBD600D0 Q26801511-D3C51C7C-2DBE-48D0-B187-423870720C5B Q27005850-F702FDCA-A45F-4C0C-8013-F3E0B2464561 Q28080281-949E037B-4DE2-4B65-A4FE-E41D0DA80401 Q28115468-2355CF9C-A9E9-4359-9E18-82D7E549690E Q28384176-021360F9-94DE-44F5-9622-F8DA869C623F Q28391713-F181CC7A-0E11-43B7-A666-05D2956313A9 Q30439971-C7397DD8-D18D-41A1-9054-4C758736D74D Q33555052-16D81406-EA48-4D7C-B8FC-1ABF0A18B911 Q33688606-DF2011F9-7C7E-40F5-A3A6-74BBC5A8E897 Q33724231-24C7CA6B-A61E-4D27-834C-49EB34489F7A Q33761894-1BF7145B-1416-40F6-A1B4-A6C72BA5FC46 Q33980238-F0265E84-02FF-4BE1-A9C2-E26CFF360713 Q34036145-6A8724D3-BBF7-456D-A5DB-863E20D765E3 Q34284404-1551F8E6-5FBD-44EF-ABB7-C070FA78CFDE Q34328740-C18F4333-B012-48E8-899B-8B8A1D38B3C7 Q34393036-34A4FC41-E2D0-4A9C-A5A1-6986606E9CE4 Q34414722-01B274DB-58FF-4315-B573-4F58456AB928 Q34455269-487547E2-237A-4FD0-87FD-A3ACD4650C02 Q34485641-51AD6C3B-3B92-41DF-AB74-F3B7863FBC89 Q34936657-EC22F262-4070-4DF4-9BB3-FD6DD5543A39 Q35028814-37EA7E64-12BD-41BD-A0DC-08361C4F7CCA Q35029955-00C8F840-7232-49F1-A4F9-FFB7E8D7367C Q35042133-F233D53E-0BE0-4C49-9EB6-06470C98C297 Q35107341-DB081487-A31B-445D-8513-F499BEF52108 Q35123077-C4E4EAE5-79CC-4BCA-9265-7FB122007E6C Q35128373-90AE7647-47A9-444A-89D6-2A52DD94B8CC Q35215896-84E30CFC-7F0E-400C-B308-46D67965C083 Q35233796-5FF4F9FB-213D-4257-B212-91FA07BD450E Q35284740-CFE28417-A96D-4178-8B32-8AA934FFE3E2 Q35319936-FC0C7F73-607F-4017-87A1-905BEF742487 Q35752063-A69FEB81-55E6-4DB2-A86F-9C7C3FF5F8C5 Q35904190-51B3B88F-028E-4A5D-8946-A036B2FE56DC Q35955250-16ABC7D6-4B1D-428E-BD6D-5BF78706D978 Q36110358-DD8D5DD0-54CC-4A0F-B992-A8DDCDFC8C37 Q36197033-D62D16F6-3F91-4981-8F6E-3035DDE34BFC Q36208525-1BDAA24F-1EEB-40F0-830D-A1A3A0C35C91 Q36422024-E1B09F75-20FA-4B62-ACA7-5567F13EF497

P2860

MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

http://www.wikidata.org/entity/Q35378724

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@ast

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@en

type

label

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@ast

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@en

prefLabel

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@ast

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma.

@en

P1433

Q35378724-78695D39-1900-4663-B915-256FE2E0E3FE

P1476

Q35378724-466FDE87-B3F9-4909-A59A-0EF505648A89

P2093

Q35378724-0EC4039C-C79D-45D3-9A35-F67705D0AA7E

Q35378724-11FB9F89-799F-4E49-9211-27B2824F4888

Q35378724-24A2B8DD-C2B8-47A4-A0D9-E7B6B4F11ABB

Q35378724-6A6BBD24-4423-4995-9EEB-B2DCE5559A87

Q35378724-6B2F98B0-C38D-4891-ADC4-50F0F12EFDB8

Q35378724-78EE61BF-B961-4BF9-849B-278062F6A07E

Q35378724-938E9825-F176-4197-B0E3-665F2AC5BF2B

Q35378724-98B764CE-6970-4CA9-A964-9653ECC23447

Q35378724-9AD1EB3F-D248-464D-A1EB-4C50C6C2EB77

Q35378724-9FB38464-1D9A-4F11-A679-732ADE52AECB

P2860

Q35378724-00B73825-8879-4038-9E10-6B4A89F10AF0

Q35378724-0124D563-71C4-4295-A104-18DFDC278DD6

Q35378724-06009553-B1E2-4F2A-AF35-F3AD933718B5

Q35378724-08D3B487-CAE2-4727-A841-7B9EBD69F7A2

Q35378724-0C62E232-4666-4E64-B6CB-B43FE78B5B1E

Q35378724-18899085-7C84-417B-AA01-42414C5FF02C

Q35378724-1D8EE8F4-B875-46F7-8E3D-C9356F5FE672

Q35378724-2AAE6063-DA5C-43AA-9075-9FDA81C379E1

Q35378724-2EAE8350-5D39-404B-B800-0268B1359328

Q35378724-333876B1-534E-4FC8-90B1-3C30E8AA294A

P304

Q35378724-E9625905-4F19-4027-989C-D3EDC29F13B6

P31

Q35378724-02B985F1-0587-4BCD-8334-43D736CA26AA

P356

Q35378724-11083B64-A72F-4224-A333-F0B2F97AD354

P407

Q35378724-65AAD74E-DDF1-45CA-89D1-85CE8AEAC3E0

P433

Q35378724-D221B18C-B7CA-4D90-9ACF-79D0B807876A

P478

Q35378724-4D858E72-8E77-48A1-B4D0-AA7ACF3BDFBE

P50

Q35378724-47E900FD-DB40-4814-9BC5-12073EA9917B

Q35378724-656FAB77-2AFD-4054-AC12-7F0484CCF221

P577

Q35378724-D5DDBED6-5379-4C8D-8F38-1895A285BE80

P698

Q35378724-00C1A9B7-AD36-4B38-BF0E-EE9CD393318E

P921

Q35378724-DF2F1353-9FF0-4E38-8CA5-4D403F1302D0

P932

Q35378724-8BE3789E-56EB-4574-8472-2A68ED9C0C1D

P356

JBC.M111.270561

P1433

Journal of Biological Chemistry

P1476

MicroRNA-99a inhibits hepatoce ...... with hepatocellular carcinoma

@en

P2093

Chunmei Wang

http://www.w3.org/2001/XMLSchema#string

Dong Li

http://www.w3.org/2001/XMLSchema#string

Guoshan Ding

http://www.w3.org/2001/XMLSchema#string

Jin Hou

http://www.w3.org/2001/XMLSchema#string

Li Lin

http://www.w3.org/2001/XMLSchema#string

Nan Li

http://www.w3.org/2001/XMLSchema#string

Peng Zhang

http://www.w3.org/2001/XMLSchema#string

Pin Wang

http://www.w3.org/2001/XMLSchema#string

Qian Zhang

http://www.w3.org/2001/XMLSchema#string

Weiping Zhou

http://www.w3.org/2001/XMLSchema#string

P2860

Human MicroRNA targets

mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E

Downregulation of miR-122 in the rodent and human hepatocellular carcinomas

MicroRNA expression, survival, and response to interferon in liver cancer

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

The functions of animal microRNAs

A microRNA polycistron as a potential human oncogene

Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma

P304

36677-36685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.270561

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21878637

http://www.w3.org/2001/XMLSchema#string

P921

P932

3196113

http://www.w3.org/2001/XMLSchema#string